Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Search content at Experts@Minnesota
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Nanoparticle-mediated p53 gene therapy for tumor inhibition
Blanka Sharma
, Wenxue Ma
, Isaac Morris Adjei
, Jayanth Panyam
, Sanja Dimitrijevic
, Vinod Labhasetwar
Pharmaceutics
Research output
:
Contribution to journal
›
Article
›
peer-review
35
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Nanoparticle-mediated p53 gene therapy for tumor inhibition'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Nanoparticles
100%
P53 Gene Therapy
100%
Tumor Inhibition
100%
P53 Gene
33%
Local Injection
33%
P53 DNA
33%
Animal Survival
33%
Gene Expression
16%
Gene Therapy
16%
In Cancer
16%
Intravenous Injection
16%
Tumor
16%
Imaging Studies
16%
Tumor Growth
16%
Tumor Targeting
16%
Radiation Therapy
16%
Human Cancer
16%
Prostate Cancer Cells
16%
Genetic Disease
16%
Intravenous Administration
16%
Cancer Cells
16%
Polymeric Nanoparticles
16%
Intratumoral Injection
16%
Intracellular Delivery
16%
Plasmid DNA (pDNA)
16%
Non-viral Vectors
16%
P53 Tumor Suppressor Gene
16%
Tumor Tissue
16%
Tumor Growth Inhibition
16%
Tumor Xenograft
16%
Aggressive Disease
16%
P53 Protein Expression
16%
Targeting Efficiency
16%
Poly(lactic-co-glycolic acid)
16%
Resistance to Chemotherapy
16%
Intravenous Dose
16%
Antiproliferative Effect
16%
Human p53
16%
Pharmacology, Toxicology and Pharmaceutical Science
Nanoparticle
100%
Cancer Inhibition
100%
Protein P53
100%
Neoplasm
30%
Malignant Neoplasm
20%
Tumor Suppressor Protein
10%
Prostate Cancer
10%
Chemotherapy Regimens
10%
Genetic Disorder
10%
Tumor Growth
10%
Plasmid DNA
10%
Polyglactin
10%
Table Salt
10%
Diseases
10%